Ncats: service: calibration services for analytical instruments: non-severable : non-severable
Active Purchase Order Awarded Last action
- Contract number
- 75N98026P00480
- Awardee
-
Karebay Biochem Inc. UEI ZKCBGTN8DJH7
- Awarding agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Obligated
- $38,600
Award facts
- Opportunity
-
- NOI- Preparation of chemical compounds needed for a Janus kinase 2 (JAK2) enzyme project Special Notice · 75N98026Q00251 · Posted Apr 23, 2026
- Contract value 100% obligated
- $38,600.00 Current and potential, with all options
- Completion date 47% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 325199 All Other Basic Organic Chemical Manufacturing
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
About this award
The National Center for Advancing Translational Sciences (NCATS) awarded a purchase order to Karebay Biochem Inc. for $38,600 on May 11, 2026, to provide calibration services for analytical instruments. Work is performed in Rockville, Maryland. The order covers synthesis of two specialized JAK2 inhibitor compounds at 95% purity, confirmed by NMR and LCMS analysis, for brain cancer cell assays: 10 grams of 4-amino-N,N-dicyclopropyl-6-ethyl-1-methyl-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine-7-carboxamide and 2.5 grams of N,N-dicyclopropyl-4-((1,5-dimethyl-1H-pyrazol-3-yl)amino)-6-ethyl-1-methyl-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine-7-carboxamide. The contractor must deliver within two months of order approval. This procurement originated from Special Notice 75N98026Q00251, a sole-source acquisition under FAR 6.302-1 and conducted under FAR Part 12 and Part 13 simplified procedures. Ultimate completion is May 10, 2027.
Quick answers
Who was awarded contract 75N98026P00480?
75N98026P00480 was awarded to Karebay Biochem Inc. by Office of Logisitics and Acquisition Operations (National Institutes of Health) on May 11, 2026.
How much is contract 75N98026P00480 worth?
The government has obligated $38,600 on 75N98026P00480.
Which agency awarded contract 75N98026P00480?
Office of Logisitics and Acquisition Operations (National Institutes of Health) awarded 75N98026P00480, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N98026P00480 competed?
The extent of competition for 75N98026P00480 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award